MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, 350108, P. R. China.
Fujian Science & Technology Innovation Laboratory for, Optoelectronic Information of China, Fuzhou, 350108, P. R. China.
Angew Chem Int Ed Engl. 2021 Jun 1;60(23):12868-12875. doi: 10.1002/anie.202100002. Epub 2021 May 5.
To date, hydrogen (H ) therapy has received widespread attention. However, X-ray triggered sustainable H -producing materials with controlled release for cancer treatment have not been reported. Herein, an X-ray triggered sustainable in situ H producing platform, Au NR-TiO @ZnS:Cu,Co-A(Au-TiO @ZnS), composed of Au-amorphous TiO nano-dumbbell-shaped heterostructure coated with long afterglow particles, was developed for cancer synergistic H -radiotherapy. The mechanism of H production was verified by theoretical calculations and in vitro experiments. Changes in the apoptosis pathway caused by the synergistic effect of H and radiotherapy were reported. Guided by its excellent photoacoustic imaging capabilities, mice with orthotopic liver cancer achieved excellent therapeutic effects and low inflammatory side effects, suggesting that Au-TiO @ZnS has promising application potential for cancer treatment and prognosis.
迄今为止,氢气(H2)治疗受到了广泛关注。然而,尚未有报道称 X 射线触发的可持续性 H2 产生材料具有可控释放,可用于癌症治疗。在此,开发了一种 X 射线触发的可持续原位 H2 产生平台,Au NR-TiO@ZnS:Cu,Co-A(Au-TiO@ZnS),由 Au-非晶态 TiO 纳米哑铃形异质结构包覆长余辉颗粒组成,用于癌症协同 H2-放射治疗。通过理论计算和体外实验验证了 H2 产生的机制。报道了 H2 和放射治疗协同作用引起的细胞凋亡途径的变化。在其出色的光声成像能力的指导下,荷肝癌小鼠实现了优异的治疗效果和低炎症副作用,表明 Au-TiO@ZnS 具有用于癌症治疗和预后的广阔应用前景。